Sentences with phrase «price than a growth»

Due to this fundamental distinction, a value stock is often traded at a more affordable price than a growth stock.

Not exact matches

Tuesday's below - consensus ISM and construction spending report, along with a hotter - than - expected prices paid report, played perfectly into the bear narrative of slower growth and higher inflation.

While gold is often considered an inflation hedge, Julius Baer said in a note, the fact that price pressures were being driven by confidence about growth rather than dollar weakness and rising oil prices meant it was failing to react positively.

Unlike Grantham, Shilling believes that low global growth will continue to keep pressure on the price of oil, especially when Saudi Arabia, the world's most influential producer, can continue to pump up oil for less than $ 10 a barrel.

That's massive growth, no matter how you look at it, which helped push the stock price (NFLX) up by more than 139 % last year.

The collapse of oil prices wiped out profits and killed the incentive to expand in the oil patch, and economic growth of less than 2 % offers little incentive for non-energy companies to expand.

Meanwhile, the Labor Department is expected to report that U.S. producer prices rose 0.3 % last month, which is slightly higher than the previous month's growth, and the consumer price index also likely improved by 0.3 % in May.

If oil prices do not escalate, the government's budget outlook will deteriorate in the billions of dollars, through a combination of slow economic growth and lower than anticipated inflation.

Another Principal fund, the $ 7.5 billion Principal LargeCap Growth I fund managed by T. Rowe Price, marked down its Uber stake by about another 8 %, a total reduction of more than 12 % since April.

More than two dozen domestic solar mounting equipment manufacturers and their domestic suppliers told the ITC, in a letter sent in August, that the tariffs requested by Suniva would more than double the price of solar panels in the U.S. and undercut the cost - competitiveness of solar and reversing its high growth trajectory.

In the October report, there were five: stronger - than - expected U.S. growth; higher - than - expected oil prices; the possibility that weak business investment had altered the economy's potential; slower growth in less advanced economies such as China; and a tilt to saving from spending by Canada's heavily indebted households.

Failure of prices to recover raises the prospect of even deeper cuts to investment by oil and gas companies next year and would likely result in Canada's economy remaining on a slower growth path than the 2.2 per cent pace we are expecting.»

But if revenue growth is lower than anticipated, and subscriptions fall while marketing spending increases to bring consumers back, the share price could drop to $ 250.

Last week, for example, CVS said that prescription drug «hyperinflation» — defined as price increases of more than 100 % and as much as 5,000 % — contributed less than 0.7 % to overall cost growth for its PBM clients.

The price changers reported 28 % revenue growth, nearly 8 % higher than the fixed pricers.

Sanofi CEO Olivier Brandicourt said that his company would rely on the U.S. national health expenditures (NHE) growth projection to cap price increases other than for a «sound reason» (in which case the firm would disclose the reasoning behind the bigger hike).

BlackBerry still owns more than 40 % of the North American smartphone market, and though it continues to show healthy growth in emerging markets, investors worry about the declining average sale price for its products, about RIM's failure to make a dent in the consumer marketplace, and about the growing sense that it no longer offers an enterprise user anything that one of its sexier rivals doesn't do as well or better.

Williamson said the PMIs pointed to fourth - quarter GDP growth of 0.1 percent, weaker than the 0.2 percent predicted in a Reuters poll last week, but that very weak expansion is coming at a cost: firms cut prices for the 33rd month.

Euro zone businesses are ending 2014 in slightly better shape than thought but growth remains weak and firms are still cutting prices to encourage trade, surveys showed.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

According to a Bain analysis, 45 % of TSR growth at publicly traded global healthcare companies over the past five years came from an expansion of price - to - earnings multiples — that is more than growth from either revenue or earnings.

But anyone hoping for the kind of stock growth Shoppers enjoyed over the past decade — when its share price climbed from less than $ 18 to, at one point, over $ 55 — will be disappointed.

At this point then yes price appreciation is secondary bonus and we have an arguement of how and why Real Estate can be better than Growth Stocks in some scenarios and for some investors.

The report added: «The growth in this market is more robust, driven by increases in volumes rather than prices.»

But there's another tool in the pan-Canadian framework on clean growth and climate change that will cut far more carbon pollution than federal carbon pricing, and you probably haven't heard of it.

The tight supply is pushing home prices higher, considerably faster than income growth.

The illusion is growth in revenues, EBITDA, or non-GAAP metrics that overlook the price paid for the acquiree, which, more often than not, is so high that the real cash flows of the deal are highly negative and dilutive to shareholder value.

Chair Yellen, with real growth over the recovery a little slower than we thought, output gaps and job market slack still on the scene, prices appearing to decelerate and wages / compensation revealing little in the way of threatening pressures, try as I might — and I repeat, I'm solidly in your camp — I don't see the rationale for tightening, even a little.

This would sharply enhance growth rates during the expansion phase, much like margin borrowing enhances returns when market prices are rising faster than the debt servicing costs, but at the expense of sub-par performance once conditions reverse.

Execution of the company's strategy resulted in strong earnings growth during the life of NEP's investment and an exit multiple of over 3x greater than the initial purchase price.

With the much lower than expected oil prices, we can no longer expect Alberta to be the driver of economic growth in Canada.

Such caution is especially warranted given the asymmetric risk scenario recently outlined by Fed governor Lael Brainard (the risks of weaker demand are greater than those of accelerating price growth).

Similarly, the growth in the Aboriginal population is much faster than the growth in the general population and prices experienced on reserves are significantly higher than in urban centers.

World growth will remain low on average but negative in the UK and Europe; price inflation will remain sufficiently subdued for a while longer so as to impose no constraint on monetary expansion; central banks will sustain a regime of negative real interest rates and rapid monetary expansion; the risk of a eurozone collapse is off the table for now; finally, stock markets should continue to perform better than expected, even though the four - year old cyclical bull market is long by historical standards.

The swift recovery in resource prices was a significant factor in explaining why Canada recovered more quickly than other G7 countries, and probably explains why Australia only saw a short - lived reduction in the rate of growth of GDP during 2008 - 09.

Assuming even a 4 % annual growth rate in prices — inflation plus about 1 to 2 percentage points — property prices should be significantly higher than where they are now.

For most of the public, the reputation of the Federal Reserve will continue to be measured mainly by our success in promoting economic growth with price stability, rather than by our interactions with educators and students.

Securing the European market with lower prices is also prudent, but it is a smaller market than Asia, both in terms of demand and demand growth prospects.

And on the way down — even as commodity prices fell sharply and mining investment declined — growth in GDP, employment and wages was only a little weaker than average.

It is worth noting, however, that we believe it is incumbent on the government to keep spending within declared levels, and to appropriately apply any unexpected gains (i.e. from a stronger than forecast GDP growth, higher energy prices, etc.) to the deficit and thus hasten the return to a balanced budget.

Prices for these expenditures can, and do, rise with less of a tie to expected growth in the economy, and therefore such price rises tend to detract from incomes more than they're likely to support them.

The r - squared value of 0.0006 in Figure 1 shows that EPS growth over the past five years explains less than one tenth of one percent of the difference in price between stocks in the S&P 500.

This includes the possibility of lower oil prices — their forecast for oil prices continues to be relatively positive - slower - than - expected growth in the EURO zone and in emerging economies, especially in China.

Natural Gas Natural gas futures were among the quarter's key decliners -LRB--7.5 %, to US$ 2.73 per million British thermal units) as production growth outweighed seasonal consumption and higher exports of the fuel.1 Spot prices saw an even larger drop of 20.6 % (to US$ 2.81) as the support of December's weather - related demand spikes faded and a more normal winter pattern developed.1 Natural gas generally took its downward price cues from elevated US production and growth in the natural gas - focused rig count, which increased from 179 to 194 in March alone.2 Despite the price drop, traders remained optimistic given surging US shale - gas exports and a supply deficit that was 20 % larger than the five - year average at March - end, the biggest in four years.3 Moreover, total natural gas inventories of 1.38 trillion cubic feet were nearly 33 % below their year - ago level.3 Meanwhile, the market appeared focused on an anticipated production surge (2018 is projected to be a record growth year for gas supplies) and may have overlooked intensifying demand as US exports increasingly helped drain supplies.

With over 30 years of investment experience, David co-founded the leading Baltimore - based growth investment firm Camden Partners in 1995 after spending more than a decade investing in small cap companies with T. Rowe Price.

In 2015, news reports revealed that Uber had an operating loss of $ 470 million on $ 415 million in revenue, confirming suspicions that the company has been bleeding money for the sake of achieving steep growth and acquiring market share.391 In China, the company has lost more than $ 1 billion a year.392 The strategy of aggressive price competition and brazen leadership coupled with soaring growth prompted immediate comparisons to Amazon.393 Like Amazon, Uber has drawn immense interest from investors.

Boosted by the bullish supply - demand reports, oil prices rallied on Monday, with Brent hitting a more than two - year high on strong oil demand growth and the threat to Kurdish oil exports over the referendum on independence.

«I would argue that the revenue growth is stronger than the subscriber potential with pricing power that we see globally,» he said.

With better - than - reported fundamentals, a long history of dividend growth, and undervalued stock price, this firm earns a spot on this month's Dividend Growth Stocks Model Portfolio and is this week's Longgrowth, and undervalued stock price, this firm earns a spot on this month's Dividend Growth Stocks Model Portfolio and is this week's LongGrowth Stocks Model Portfolio and is this week's Long Idea.

Lower year - over-year increases in gas prices, as well as more difficult comps resulted in slightly lower card sales growth than in the prior quarter year - over-year increase.